UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 13, 2024 (September 10, 2024)
Enphys Acquisition Corp.
(Exact name of registrant as specified in its charter)
|
|
001-40879
|
87-2010879
|
|
(State or other jurisdiction of incorporation or
organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
|
100 Wall Street
20th Floor
New York,
New York
|
|
10005
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(646) 854-6565
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the
following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each
exchange
on which
registered
|
|
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
|
|
OTC Pink:
|
|
|
| |
|
|
|
|
|
Class A ordinary shares, par value $0.0001 per share
|
|
OTC Pink:
NFSCF
|
|
N/A
|
| |
|
|
|
|
|
Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary shares at an exercise price of $11.50
|
|
OTC Pink:
NFSWF
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the
Securities Exchange Act of 1934.
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On September 10, 2024, Eva Redhe, an independent director on the Board of Directors of Enphys Acquisition Corp., a Cayman Islands exempted company (the “Company”), informed the Company that she has resigned from the Board of Directors
of the Company, including from her committee positions on the audit committee, the compensation committee, and the nominating and corporate governance committee, effective immediately. Ms. Redhe has served as a director of the Company since
2021. Ms. Redhe's decision to resign is due to personal reasons and is not due to any disagreement with the Company on any matter.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
Dated: September 13, 2024
|
| |
|
| |
ENPHYS ACQUISITION CORP.
|
| |
|
| |
By:
|
/s/ Jorge de Pablo
|
|
| |
Name:
|
Jorge de Pablo
|
| |
Title:
|
Chief Executive Officer
|